多发性硬化症中发作的发生率和决定因素:随机临床试验的元分析

Valeria Pozzilli1,2, Shalom Haggiag3, Massimiliano Di Filippo4

  • 1Unit of Neurology, Neurophysiology and Neurobiology, Department of Medicine and Surgery, Campus Bio-Medico University, Roma, Lazio, Italy.

概括

多发性硬化症 (MS) 患者的发作发病率明显高于普通人群. 疾病的进展和某些药物,如斯芬戈-1-酸盐受体调节剂,会增加这种风险.